{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:09:37Z","timestamp":1788800977573,"version":"build-2803163510"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,7]]},"DOI":"10.7759\/cureus.115901","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:44:51Z","timestamp":1788799491000},"source":"Crossref","is-referenced-by-count":0,"title":["Methotrexate-Associated Lymphoproliferative Disorder Presenting As Disseminated Metastatic Malignancy: A Case Report"],"prefix":"10.7759","author":[{"given":"Carolina","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana C","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro A","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen JS","year":"2023","unstructured":"Smolen JS, Landew\u00e9 RB, Bergstra SA, et al.. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023, 82:3-18. 10.1136\/ard-2022-223356","journal-title":"Ann Rheum Dis"},{"key":"ref2","article-title":"Haematolymphoid Tumours","year":"2024","unstructured":"Haematolymphoid Tumours. International Agency for Research on Cancer Publications, 2024."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo E","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, et al.. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022, 140:1229-53. 10.1182\/blood.2022015851","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15894","article-title":"Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis","volume":"114","author":"Tanaka K","year":"2023","unstructured":"Tanaka K, Ichikawa A, Umezawa N, et al.. Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis. Cancer Sci. 2023, 114:3719-27. 10.1111\/cas.15894","journal-title":"Cancer Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12116","article-title":"Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression","volume":"91","author":"Ichikawa A","year":"2013","unstructured":"Ichikawa A, Arakawa F, Kiyasu J, et al.. Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol. 2013, 91:20-8. 10.1111\/ejh.12116","journal-title":"Eur J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.625101","article-title":"Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis","volume":"53","author":"Tokuhira M","year":"2012","unstructured":"Tokuhira M, Watanabe R, Nemoto T, et al.. Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis. Leuk Lymphoma. 2012, 53:616-23. 10.3109\/10428194.2011.625101","journal-title":"Leuk Lymphoma"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13415","article-title":"Methotrexate-associated lymphoproliferative disorder with an osteolytic vertebral lesion in an elderly patient with rheumatoid arthritis: a case report","volume":"46","author":"Hirata C","year":"2021","unstructured":"Hirata C, Kenzaka T, Akita H. Methotrexate-associated lymphoproliferative disorder with an osteolytic vertebral lesion in an elderly patient with rheumatoid arthritis: a case report. J Clin Pharm Ther. 2021, 46:1178-81. 10.1111\/jcpt.13415","journal-title":"J Clin Pharm Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.6755-25","article-title":"A case of methotrexate-induced other iatrogenic immunodeficiency-associated lymphoproliferative disorder with diffuse ground-glass opacities diagnosed using a cryobiopsy","author":"Fujii T","year":"2026","unstructured":"Fujii T, Asami-Noyama M, Ohata S, et al.. A case of methotrexate-induced other iatrogenic immunodeficiency-associated lymphoproliferative disorder with diffuse ground-glass opacities diagnosed using a cryobiopsy. Intern Med. 2026, 6755-25. 10.2169\/internalmedicine.6755-25","journal-title":"Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/525762-methotrexate-associated-lymphoproliferative-disorder-presenting-as-disseminated-metastatic-malignancy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:44:51Z","timestamp":1788799491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/525762-methotrexate-associated-lymphoproliferative-disorder-presenting-as-disseminated-metastatic-malignancy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.115901","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,7]]}}}